The 2018 Pickart review documented that GHK-Cu affects 31.2% of human genes, including collagen synthesis, VEGF production, and TGF-1 suppression
This aligns closely with the approximately 15% average weight loss seen with injectable Wegovy in earlier phase 3 trials, although the studies were not head-to-head and involved different designs and populations
In fact, by helping regulate blood sugar and reducing inflammation associated with excess weight, GLP-1 therapy may support overall immune health
Yang, Y., Mihajlovic, M., Janssen, M
Once-weekly treatment with 1 mg semaglutide reduced the risk of the primary composite outcome by 24% and delayed the progression of kidney dysfunction over a period of 4 years (75)